David T. Scadden

Active 1984–2025

Also published as
David T Scadden
210
Papers
65,695
Citations
126
h-index
207
i10-index

Citations

Citations per year for David T. Scadden1957: 1 citations1986: 1 citations1987: 6 citations1988: 4 citations1989: 11 citations1990: 29 citations1991: 32 citations1992: 22 citations1993: 30 citations1994: 22 citations1995: 46 citations1996: 55 citations1997: 47 citations1998: 47 citations1999: 51 citations2000: 81 citations2001: 123 citations2002: 173 citations2003: 193 citations2004: 294 citations2005: 394 citations2006: 476 citations2007: 645 citations2008: 710 citations2009: 693 citations2010: 736 citations2011: 818 citations2012: 747 citations2013: 781 citations2014: 824 citations2015: 838 citations2016: 751 citations2017: 812 citations2018: 751 citations2019: 2,091 citations2020: 2,227 citations2021: 2,258 citations2022: 1,684 citations2023: 1,194 citations2024: 1,714 citations2025: 841 citations2026: 29 citations1958–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,540 citing papers, 33.6% of this breakdownChina: 3,021 citing papers, 11.9% of this breakdownGermany: 1,600 citing papers, 6.3% of this breakdownUnited Kingdom: 1,522 citing papers, 6% of this breakdownItaly: 1,075 citing papers, 4.2% of this breakdownJapan: 849 citing papers, 3.3% of this breakdownFrance: 828 citing papers, 3.3% of this breakdownCanada: 709 citing papers, 2.8% of this breakdownNetherlands: 593 citing papers, 2.3% of this breakdownAustralia: 589 citing papers, 2.3% of this breakdownSwitzerland: 558 citing papers, 2.2% of this breakdownSpain: 518 citing papers, 2% of this breakdown
0%33.6%Other 19.8%

Fields

  • Medicine45%
  • Biochemistry, Genetics and Molecular Biology36%
  • Immunology and Microbiology9.7%
  • Engineering2.8%
  • Materials Science2.4%
  • Neuroscience2.2%
  • Other1.9%

Topics

  • Mesenchymal stem cell research3.5%
  • Hematopoietic Stem Cell Transplantation3.5%
  • Immune cells in cancer2.6%
  • Cancer Cells and Metastasis2.3%
  • Acute Myeloid Leukemia Research2.3%
  • Single-cell and spatial transcriptomics2%
  • Other83.8%

Coauthors

All papers

Open in search
  1. The bone marrow niche for haematopoietic stem cells

    Authors: , - Nature 2014 cited by 2,433

  2. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

    Authors: , , , , , , , , , - Nature 2010 cited by 3,371

  3. Bayesian approach to single-cell differential expression analysis

    Authors: , , - Nature Methods 2014 cited by 1,542

  4. A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 929

  5. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 cited by 247

  6. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 873

  7. Direct measurement of local oxygen concentration in the bone marrow of live animals

    Authors: , , , , , , , , , , , , , , - Nature 2014 cited by 1,161

  8. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

    Authors: , , , , , , , , , , , , , , , , , - Cancer Cell 2021 cited by 275

  9. Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF high neutrophils

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David T. Scadden, Ralph Weissleder, Mikaël J. Pittet - Science 2017 cited by 376

  10. Osteoblastic cells regulate the haematopoietic stem cell niche

    Authors: , , , , , , , , , , , , - Nature 2003 cited by 3,429

  11. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria

    Authors: , , , , , , , , , , , , , , , , - Nature 2020 cited by 343

  12. Lipid availability determines fate of skeletal progenitor cells via SOX9

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 236

  13. Distinct bone marrow blood vessels differentially regulate haematopoiesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature 2016 cited by 714

  14. Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Filip K. Świrski, Matthias Nahrendorf - Nature Medicine 2019 cited by 281

  15. Health Consequences of Thymus Removal in Adults

    Authors: , , , , - New England Journal of Medicine 2023 cited by 164

  16. BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 788

  17. Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 498

  18. The stem-cell niche as an entity of action

    Authors: - Nature 2006 cited by 1,846

  19. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche

    Authors: , , , , , , , , , , , , , , , - Nature 2011 cited by 557

  20. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2004 cited by 1,957

  21. Mesenchymal Cell Contributions to the Stem Cell Niche

    Authors: , - Cell stem cell 2015 cited by 564

  22. Endogenous Bone Marrow MSCs Are Dynamic, Fate-Restricted Participants in Bone Maintenance and Regeneration

    Authors: , , , , , , , , - Cell stem cell 2012 cited by 631

  23. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

    Authors: , , , , , , , , , , , , , , , , , , , - Leukemia 2019 cited by 246

  24. Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 174